AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/212

Authors: RIVARD A ISNER JM
Citation: A. Rivard et Jm. Isner, ANGIOGENESIS AND VASCULOGENESIS IN TREATMENT OF CARDIOVASCULAR-DISEASE, Molecular medicine (Cambridge, Mass.), 4(7), 1998, pp. 429-440

Authors: VANBELLE E MAILLARD L RIVARD A FABRE JE COUFFINHAL T KEARNEY M BRANELLEC D FELDMAN LJ WALSH K ISNER JM
Citation: E. Vanbelle et al., EFFECTS OF POLOXAMER-407 ON TRANSFECTION TIME AND PERCUTANEOUS ADENOVIRUS-MEDIATED GENE-TRANSFER IN NATIVE AND STENTED VESSELS, Human gene therapy, 9(7), 1998, pp. 1013-1024

Authors: ISNER JM
Citation: Jm. Isner, SUMMARY OF PROTOCOLS DISCUSSED AT THE JUNE 18-19, 1998 RECOMBINANT-DNA ADVISORY-COMMITTEE (RAC) MEETING, Human gene therapy, 9(14), 1998, pp. 2152-2161

Authors: LUO ZY ASAHARA T TSURUMI Y ISNER JM SYMES JF
Citation: Zy. Luo et al., REDUCTION OF VEIN GRAFT INTIMAL HYPERPLASIA AND PRESERVATION OF ENDOTHELIUM-DEPENDENT RELAXATION BY TOPICAL VASCULAR ENDOTHELIAL GROWTH-FACTOR, Journal of vascular surgery, 27(1), 1998, pp. 167-173

Authors: HENRY TD ROCHASINGH K ISNER JM KEREIAKES DJ GIORDANO FJ SIMONS M LOSORDO DW HENDEL RC BONOW RO ROTHMAN JM BORBAS ER MCCLUSKEY ER
Citation: Td. Henry et al., RESULTS OF INTRACORONARY RECOMBINANT HUMAN VASCULAR ENDOTHELIAL GROWTH-FACTOR (RHVEGF) ADMINISTRATION TRIAL, Journal of the American College of Cardiology, 31(2), 1998, pp. 65-65

Authors: FABRE JE RIVARD A MAGNIN M ISNER JM
Citation: Je. Fabre et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH QUINAPRILATE STIMULATESANGIOGENESIS IN A RABBIT MODEL OF HINDLIMB ISCHEMIA, Journal of the American College of Cardiology, 31(2), 1998, pp. 239-239

Authors: SCHAINFELD R ROSENFIELD K ISNER JM HALEY L RAUH G RAKAUSKAS P IRWIN W
Citation: R. Schainfeld et al., WALKING IMPROVEMENT QUESTIONNAIRE - A POTENTIAL STANDARDIZED INSTRUMENT FOR EVALUATING FUNCTIONAL IMPROVEMENT AFTER PERIPHERAL ANGIOPLASTY, Journal of the American College of Cardiology, 31(2), 1998, pp. 521-521

Authors: BAUMGARTNER I ISNER JM
Citation: I. Baumgartner et Jm. Isner, STIMULATION OF PERIPHERAL ANGIOGENESIS BY VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF), VASA, 27(4), 1998, pp. 201-206

Authors: ISNER JM
Citation: Jm. Isner, ARTERIAL GENE-TRANSFER OF NAKED DNA FOR THERAPEUTIC ANGIOGENESIS - EARLY CLINICAL-RESULTS, Advanced drug delivery reviews, 30(1-3), 1998, pp. 185-197

Authors: SPYRIDOPOULOS I BROGI E KEARNEY M SULLIVAN AB CETRULO C ISNER JM LOSORDO DW
Citation: I. Spyridopoulos et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR INHIBITS ENDOTHELIAL-CELL APOPTOSIS INDUCED BY TUMOR-NECROSIS-FACTOR-ALPHA - BALANCE BETWEEN GROWTH AND DEATH SIGNALS (VOL 29, PG 1321, 1997), Journal of Molecular and Cellular Cardiology, 30(4), 1998, pp. 897-897

Authors: MUROHARA T ASAHARA T SILVER M BAUTERS C MASUDA H KALKA C KEARNEY M CHEN DH CHEN DF SYMES JF FISHMAN MC HUANG PL ISNER JM
Citation: T. Murohara et al., NITRIC-OXIDE SYNTHASE MODULATES ANGIOGENESIS IN RESPONSE TO TISSUE ISCHEMIA, The Journal of clinical investigation, 101(11), 1998, pp. 2567-2578

Authors: WITZENBICHLER B MAISONPIERRE PC JONES P YANCOPOULOS GD ISNER JM
Citation: B. Witzenbichler et al., CHEMOTACTIC PROPERTIES OF ANGIOPOIETIN-1 AND ANGIOPOIETIN-2, LIGANDS FOR THE ENDOTHELIAL-SPECIFIC RECEPTOR TYROSINE KINASE TIE2, The Journal of biological chemistry, 273(29), 1998, pp. 18514-18521

Authors: ASAHARA T CHEN DH TAKAHASHI T FUJIKAWA K KEARNEY M MAGNER M YANCOPOULOS GD ISNER JM
Citation: T. Asahara et al., TIE2 RECEPTOR LIGANDS, ANGIOPOIETIN-1 AND ANGIOPOIETIN-2, MODULATE VEGF-INDUCED POSTNATAL NEOVASCULARIZATION, Circulation research, 83(3), 1998, pp. 233-240

Authors: SHYU KG MANOR O MAGNER M YANCOPOULOS GD ISNER JM
Citation: Kg. Shyu et al., DIRECT INTRAMUSCULAR INJECTION OF PLASMID DNA ENCODING ANGIOPOIETIN-1BUT NOT ANGIOPOIETIN-2 AUGMENTS REVASCULARIZATION IN THE RABBIT ISCHEMIC HINDLIMB, Circulation, 98(19), 1998, pp. 2081-2087

Authors: ISNER JM BLAIR R VALE P SCHAINFELD RM
Citation: Jm. Isner et al., PATENCY OF DORSALIS-PEDIS ARTERY AS A PREDICTOR OF CLINICAL OUTCOME AFTER INTRAMUSCULAR GENE-TRANSFER OF PHVEGF165 IN PATIENTS WITH NONHEALING ISCHEMIC ULCERS, Circulation, 98(17), 1998, pp. 62-62

Authors: RIVARD A ASAHARA T TAKAHASHI T CHEN DH ISNER JM
Citation: A. Rivard et al., CONTRIBUTION OF ENDOTHELIAL PROGENITOR CELLS TO NEOVASCULARIZATION (VASCULOGENESIS) IS IMPAIRED WITH AGING, Circulation, 98(17), 1998, pp. 191-191

Authors: RAUH G BAUMGARTNER I PIECZEK A BLAIR R SYMES J ISNER JM
Citation: G. Rauh et al., TREATMENT OF BUERGERS-DISEASE BY INTRAMUSCULAR GENE-TRANSFER OF PHVEGF165, Circulation, 98(17), 1998, pp. 332-332

Authors: VALE PR WUENSCH DI RAUH GF ROSENFIELD KM SCHAINFELD RM ISNER JM
Citation: Pr. Vale et al., ARTERIAL GENE-THERAPY FOR INHIBITING RESTENOSIS IN PATIENTS WITH CLAUDICATION UNDERGOING SUPERFICIAL FEMORAL-ARTERY ANGIOPLASTY, Circulation, 98(17), 1998, pp. 333-333

Authors: SHYU KG VINCENT KA LUO YX MAGNER M TIO RA JIANG CW AKITA GY ISNER JM GREGORY RJ
Citation: Kg. Shyu et al., NAKED DNA ENCODING AN HYPOXIA-INDUCIBLE FACTOR 1-ALPHA (HIF-1-ALPHA) VP16 HYBRID TRANSCRIPTION FACTOR ENHANCES ANGIOGENESIS IN RABBIT HINDLIMB ISCHEMIA - AN ALTERNATE METHOD FOR THERAPEUTIC ANGIOGENESIS UTILIZING A TRANSCRIPTIONAL REGULATORY SYSTEM/, Circulation, 98(17), 1998, pp. 342-342

Authors: VALE PR LOSORDO DW SYMES JF ISNER JM
Citation: Pr. Vale et al., GENE-THERAPY FOR MYOCARDIAL ANGIOGENESIS, Circulation, 98(17), 1998, pp. 1687-1687

Authors: SHYU KG SILVER M MAGNER M YANCOPOULOS GD ISNER JM
Citation: Kg. Shyu et al., ANGIOPOIETIN-1 POTENTIATES ANGIOGENIC RESPONSE TO VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) IN HYPERCHOLESTEROLEMIC RABBIT MODEL WITH ACUTEHINDLIMB ISCHEMIA, Circulation, 98(17), 1998, pp. 2440-2440

Authors: ASAHARA T TAKAHASHI T KALKA C MASUDA H CHEN DH SILVER M ISNER JM
Citation: T. Asahara et al., A NOVEL FUNCTION FOR VEGF - MOBILIZATION OF BONE-MARROW-DERIVED ENDOTHELIAL PROGENITOR CELLS, Circulation, 98(17), 1998, pp. 3180-3180

Authors: SHYU KG VINCENT KA LUO YX MAGNER M TIO RA JIANG CW AKITA GY ISNER JM GREGORY RJ
Citation: Kg. Shyu et al., NAKED DNA ENCODING A HYPOXIA-INDUCIBLE FACTOR 1-ALPHA (HIF-1-ALPHA) VP16 HYBRID TRANSCRIPTION FACTOR ENHANCES ANGIOGENESIS IN RABBIT HINDLIMB ISCHEMIA - AN ALTERNATE METHOD FOR THERAPEUTIC ANGIOGENESIS UTILIZING A TRANSCRIPTIONAL REGULATORY SYSTEM/, Circulation, 98(17), 1998, p.

Authors: VANBELLE E WITZENBICHLER B CHEN DH SILVER M CHANG L SCHWALL R ISNER JM
Citation: E. Vanbelle et al., POTENTIATED ANGIOGENIC EFFECT OF SCATTER FACTOR HEPATOCYTE GROWTH-FACTOR VIA INDUCTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR - THE CASE FORPARACRINE AMPLIFICATION OF ANGIOGENESIS/, Circulation, 97(4), 1998, pp. 381-390

Authors: BAUMGARTNER I PIECZEK A MANOR O BLAIR R KEARNEY M WALSH K ISNER JM
Citation: I. Baumgartner et al., CONSTITUTIVE EXPRESSION OF PHVEGF(165) AFTER INTRAMUSCULAR GENE-TRANSFER PROMOTES COLLATERAL VESSEL DEVELOPMENT IN PATIENTS WITH CRITICAL LIMB ISCHEMIA, Circulation, 97(12), 1998, pp. 1114-1123
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>